SUMMARY Using 24 hour pH monitoring as a reference standard, the usefulness of the acid perfusion (AP) test in predicting gastro-oesophageal reflux disease (GORD) was assessed in 71 noncardiac chest pain (NCCP) patients and 23 endoscopic oesophagitis patients. Of the 71 NCCP patients, 35 had a positive AP test (of whom 20 had an abnormal 24 hour pH) and 36 had a negative AP test (of whom 14 had an abnormal 24 hour pH study). Thus, the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the AP test in this group was 59%, 59%, 57%, and 61%, respectively. The corresponding values in the oesophagitis group were 85/%, 67%, 94%, and 40%. In the NCCP group when heartburn alone was used as the positive criterion the PPV rose to 74%. When chest pain with or without heartburn was used, however, the PPV dropped to 38%. A 'symptom index' was used to define the number of chest pain episodes that were caused by acid reflux. Only 48% of AP test positive patients had demonstrable acid mediated chest pain. In the NCCP population with a normal oesophageal examination (1) AP test reproduction of chest pain is poorly predictive of GORD; (2) AP test reproduction of heartburn is more predictive of GORD but does not ensure that the chest pain is caused by GORD; (3) a negative AP test does not exclude GORD and (4) only 48% of AP test positive patients have demonstrable acid mediated chest pain. The ambulatory 24 hour pH test may have rendered the AP test obsolete in the assessment of GORD as the cause of NCCP.
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Since its introduction 30 years ago, the acid perfusion (AP) test has gained wide acceptance. As originally described, the test was designed to assess whether chest pain or heartburn was secondary to increased oesophageal sensitivity to acid. In more recent times, the AP test has been widely used as a screening test for possible gastro-oesophageal reflux disease (GORD) in patients with non-cardiac chest pain (NCCP) and a radiologically or endoscopically normal oesophagus. The sensitivity (41-100%) and specificity (50-100%) of the test has, however, varied markedly.' These disparate results may be related to differences in patient populations, variations in the performance and interpretation of the test, and differing 'gold standards' used to define GORD.
At present the ambulatory 24 hour pH test is the most reliable method for the diagnosis of GORD. The test is labour intensive, however, requires expensive equipment, and may be uncomfortable for the patient. In contrast, the AP test is cheap and rapidly carried out. A comparison of the two tests has never been done. Therefore, our goal was to review the usefulness of the AP (Table 4) . Thus, seven of 16 patients with positive AP tests for chest pain had both a negative symptom index and a normal 24 hour pH study. Our results suggest that confidence may be misplaced in the ability of the AP test to diagnose GOR in patients with NCCP and a normal endoscopic or radiologic oesophageal examination. When either heartburn or chest pain is defined as a positive response, the AP test has a sensitivity of 59%, specificity of 59%, and a positive predictive value of 57%. Even more disturbing, the positive predictive value drops to 38% when chest pain is used as a positive criterion. Seven patients, nearly 10% of the NCCP population studied, had their chest pain reproduced during the AP test, yet had a normal 24 hour pH test and a negative symptom index. Could the AP test be identifying a further subpopulation of patients with acid mediated chest pain -that is, do these patients form part of the spectrum of the irritable oesophagus?22 One possible way to answer the former question may be to enter these patients into a placebo controlled trial using a powerful antisecretory drug, such as omeprazole, and assess their response. Such a trial should be done before the AP test is totally dismissed.
The AP test should have its greatest application in the non-cardiac chest pain population with a normal appearing oesophagus. Unfortunately, our data suggest that it is a poor screening study for GORD, especially if chest pain is used as a positive criterion. Heartburn during acid infusion may be more suggestive of GORD, but still does not ensure that the patient's chest pain is of oesophageal origin. Unfortunately, a negative AP test does not exclude GORD. Thus, the AP test has poor sensitivity, specificity and predictive value for the diagnosis of GORD. The lack of correlation between the symptom index and AP test also is disappointing. This may reflect both the artificial nature of the AP test, however, and the presence of cofactors that cannot be reproduced during this laboratory test. We believe ambulatory oesophageal 24 hour pH monitoring has rendered the AP test obsolete in the assessment of gastro-oesophageal reflux as a cause of non-cardiac chest pain. 
